La guía relaciona el diagnóstico y el tratamiento en población adulta de la leucemia linfoblástica aguda (LLA) y la leucemia mieloide aguda (LMA), como el diagnostico, el tratamiento y el seguimiento en población adulta de la leucemia mieloide crónica (LMC)....                                            
                                        
                                                                                    
                                        
                                                                                    
                                                                            
                                                                    
                                        
                                                                                    
                                                Grace, SL; 
Turk-Adawi, KI; 
Contractor, A; 
Atrey, A; 
Campbell, N; 
Derman, W; 
Melo Ghisi, GL; 
Oldridge, N; 
Sarkar, BK; 
Yeo, TJ; 
Lopez-Jimenez, F; 
Mendis, S; 
Oh, P; 
Hu, D; 
Sarrafzadegan, N.                                            
 
                                        
                                                                                    
                                        
                                                                                    
                                                "OBJECTIVE:
Cardiovascular disease is a global epidemic, which is largely preventable. Cardiac rehabilitation (CR) is demonstrated to be cost-effective and efficacious in high-income countries. CR could represent an important approach to mitigate the epidemic of cardiovascular disease in lower-resource s...                                            
                                        
                                                                                    
                                                
                                                Modèles d'organisation, 
Ressources en santé, 
Coûts des soins de santé, 
Activités de la vie quotidienne, 
Consensus, 
Maladies cardiovasculaires/diagnostic, 
Maladies cardiovasculaires, 
Traitement par les exercices physiques, 
Prestations des soins de santé, 
Analyse coût-bénéfice, 
Éducation du patient comme sujet, 
Reprise du travail, 
Comportement de réduction des risques, 
Autosoins, 
Maladies cardiovasculaires/thérapie                                             
                                        
                                                                                    
                                                                            
                                                                    
                                        
                                                                                    
                                        
                                        
                                                                                    
                                                INTRODUÇÃO: O câncer de mama é o tipo mais incidente na população feminina mundial e brasileira, excetuando-se os casos de câncer de pele não melanoma, e também uma das principais causas de morte por câncer em países desenvolvidos e em desenvolvimento. As taxas de incidência são maiores nos ...                                            
                                        
                                                                                    
                                        
                                                                                    
                                                                            
                                                                    
                                        
                                                                                    
                                        
                                        
                                        
                                                                                    
                                        
                                                                                    
                                                                            
                                                                    
                                        
                                                                                    
                                                Fitzgerald, RC; 
di, Pietro, M; 
Ragunath, K; 
Ang, Y; 
Kang, JY; 
Watson, P; 
Trudgill, N; 
Patel, P; 
Kaye, PV; 
Sanders, S; 
O'Donovan, M; 
Bird-Lieberman, E; 
Bhandari, P; 
Jankowski, JA; 
Attwood, S; 
Parsons, SL; 
Loft, D; 
Lagergren, J; 
Moayyedi, P; 
Lyratzopoulos, G; 
de, Caestecker, J.                                            
 
                                        
                                                                                    
                                        
                                                                                    
                                                These guidelines provide a practical and evidence-based resource for the management of patients with Barrett's oesophagus and related early neoplasia. The Appraisal of Guidelines for Research and Evaluation (AGREE II) instrument was followed to provide a methodological strategy for the guideline developm...                                            
                                        
                                                                                    
                                                
                                                Techniques d'ablation, 
Adénocarcinome/diagnostic, 
Oesophage de Barrett, 
Biopsie, 
Analyse coût-bénéfice, 
Techniques d'aide à la décision, 
Dépistage précoce du cancer, 
Tumeurs de l'oesophage, 
Oesophagectomie, 
Oesophagoscopie, 
Oesophage, 
Appréciation des risques, 
Facteurs de risque, 
Oesophage de Barrett/complications, 
Oesophage de Barrett/diagnostic, 
Oesophage de Barrett/économie, 
Oesophage de Barrett/thérapie, 
Tumeurs de l'oesophage/diagnostic, 
Tumeurs de l'oesophage/thérapie, 
Adénocarcinome/thérapie                                             
                                        
                                                                                    
                                                                            
                                                                    
                                        
                                                                                    
                                        
                                        
                                                                                    
                                                The aim of this guidance is to provide the interim principles that should guide the use of delamanid in conjunction with WHO-recommended MDR-TB treatment. It also specifies the essential treatment and management conditions for use of this drug, in particular the patient's eligibility criteria and safety ...                                            
                                        
                                                                                    
                                        
                                                                                    
                                                                            
                                                                    
                                        
                                                                                    
                                        
                                        
                                                                                    
                                                This guideline covers the longer-term psychological treatment and management of self-harm in people aged 8 and over. It aims to improve the quality of care and support for people who self harm and covers both single and recurrent episodes of self-harm. This guideline follows on from self-harm in over 8s:...